nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—ALB—chronic obstructive pulmonary disease	0.363	1	CbGaD
Cephalexin—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.179	0.357	CbGbCtD
Cephalexin—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0481	0.0957	CbGbCtD
Cephalexin—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0481	0.0957	CbGbCtD
Cephalexin—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0428	0.0853	CbGbCtD
Cephalexin—ALB—Prednisone—chronic obstructive pulmonary disease	0.041	0.0815	CbGbCtD
Cephalexin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0403	0.0803	CbGbCtD
Cephalexin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0272	0.0542	CbGbCtD
Cephalexin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.026	0.0517	CbGbCtD
Cephalexin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0232	0.0461	CbGbCtD
Cephalexin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0136	0.0271	CbGbCtD
Cephalexin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0128	0.0256	CbGbCtD
Cephalexin—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000929	0.00713	CcSEcCtD
Cephalexin—Gastritis—Formoterol—chronic obstructive pulmonary disease	0.000874	0.0067	CcSEcCtD
Cephalexin—Gastritis—Arformoterol—chronic obstructive pulmonary disease	0.000874	0.0067	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000871	0.00668	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.000871	0.00668	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000871	0.00668	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000853	0.00654	CcSEcCtD
Cephalexin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000842	0.00646	CcSEcCtD
Cephalexin—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000836	0.00641	CcSEcCtD
Cephalexin—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000832	0.00638	CcSEcCtD
Cephalexin—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00083	0.00637	CcSEcCtD
Cephalexin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000828	0.00635	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000825	0.00633	CcSEcCtD
Cephalexin—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000824	0.00632	CcSEcCtD
Cephalexin—Cefdinir—MPO—chronic obstructive pulmonary disease	0.000822	0.251	CrCbGaD
Cephalexin—Cefaclor—MPO—chronic obstructive pulmonary disease	0.000814	0.249	CrCbGaD
Cephalexin—Arthropathy—Prednisolone—chronic obstructive pulmonary disease	0.00081	0.00622	CcSEcCtD
Cephalexin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000788	0.00605	CcSEcCtD
Cephalexin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000782	0.006	CcSEcCtD
Cephalexin—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000764	0.00587	CcSEcCtD
Cephalexin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00076	0.00583	CcSEcCtD
Cephalexin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000756	0.0058	CcSEcCtD
Cephalexin—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000745	0.00572	CcSEcCtD
Cephalexin—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000745	0.00572	CcSEcCtD
Cephalexin—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000741	0.00569	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000739	0.00567	CcSEcCtD
Cephalexin—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000718	0.00551	CcSEcCtD
Cephalexin—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000705	0.00541	CcSEcCtD
Cephalexin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000704	0.0054	CcSEcCtD
Cephalexin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000686	0.00526	CcSEcCtD
Cephalexin—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000677	0.00519	CcSEcCtD
Cephalexin—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00518	CcSEcCtD
Cephalexin—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00518	CcSEcCtD
Cephalexin—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000673	0.00517	CcSEcCtD
Cephalexin—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000671	0.00515	CcSEcCtD
Cephalexin—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000671	0.00515	CcSEcCtD
Cephalexin—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00067	0.00514	CcSEcCtD
Cephalexin—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00067	0.00514	CcSEcCtD
Cephalexin—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000669	0.00513	CcSEcCtD
Cephalexin—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000666	0.00511	CcSEcCtD
Cephalexin—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000661	0.00507	CcSEcCtD
Cephalexin—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000657	0.00504	CcSEcCtD
Cephalexin—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000656	0.00503	CcSEcCtD
Cephalexin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000654	0.00502	CcSEcCtD
Cephalexin—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000648	0.00497	CcSEcCtD
Cephalexin—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00495	CcSEcCtD
Cephalexin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000638	0.00489	CcSEcCtD
Cephalexin—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.00489	CcSEcCtD
Cephalexin—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.00486	CcSEcCtD
Cephalexin—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000633	0.00485	CcSEcCtD
Cephalexin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000632	0.00485	CcSEcCtD
Cephalexin—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00485	CcSEcCtD
Cephalexin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000627	0.00481	CcSEcCtD
Cephalexin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000625	0.0048	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000623	0.00478	CcSEcCtD
Cephalexin—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.00473	CcSEcCtD
Cephalexin—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000617	0.00473	CcSEcCtD
Cephalexin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000608	0.00466	CcSEcCtD
Cephalexin—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000604	0.00464	CcSEcCtD
Cephalexin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00463	CcSEcCtD
Cephalexin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000602	0.00462	CcSEcCtD
Cephalexin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000599	0.0046	CcSEcCtD
Cephalexin—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000598	0.00459	CcSEcCtD
Cephalexin—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000598	0.00459	CcSEcCtD
Cephalexin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00059	0.00452	CcSEcCtD
Cephalexin—Arthropathy—Prednisone—chronic obstructive pulmonary disease	0.000589	0.00452	CcSEcCtD
Cephalexin—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000586	0.0045	CcSEcCtD
Cephalexin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000584	0.00448	CcSEcCtD
Cephalexin—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000583	0.00447	CcSEcCtD
Cephalexin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000568	0.00436	CcSEcCtD
Cephalexin—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.00434	CcSEcCtD
Cephalexin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000561	0.00431	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000548	0.0042	CcSEcCtD
Cephalexin—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000546	0.00419	CcSEcCtD
Cephalexin—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000546	0.00419	CcSEcCtD
Cephalexin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000543	0.00417	CcSEcCtD
Cephalexin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000543	0.00417	CcSEcCtD
Cephalexin—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000535	0.00411	CcSEcCtD
Cephalexin—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000535	0.0041	CcSEcCtD
Cephalexin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000532	0.00408	CcSEcCtD
Cephalexin—Cefpiramide—ALB—chronic obstructive pulmonary disease	0.00053	0.162	CrCbGaD
Cephalexin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000529	0.00406	CcSEcCtD
Cephalexin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000521	0.004	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00398	CcSEcCtD
Cephalexin—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00396	CcSEcCtD
Cephalexin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00394	CcSEcCtD
Cephalexin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000507	0.00389	CcSEcCtD
Cephalexin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000506	0.00388	CcSEcCtD
Cephalexin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000506	0.00388	CcSEcCtD
Cephalexin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000505	0.00387	CcSEcCtD
Cephalexin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.00387	CcSEcCtD
Cephalexin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000504	0.00387	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000503	0.00386	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000503	0.00386	CcSEcCtD
Cephalexin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000496	0.0038	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00378	CcSEcCtD
Cephalexin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000492	0.00377	CcSEcCtD
Cephalexin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.00372	CcSEcCtD
Cephalexin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000485	0.00372	CcSEcCtD
Cephalexin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00367	CcSEcCtD
Cephalexin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000478	0.00366	CcSEcCtD
Cephalexin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00365	CcSEcCtD
Cephalexin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00365	CcSEcCtD
Cephalexin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00365	CcSEcCtD
Cephalexin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00365	CcSEcCtD
Cephalexin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000471	0.00362	CcSEcCtD
Cephalexin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000471	0.00362	CcSEcCtD
Cephalexin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.0036	CcSEcCtD
Cephalexin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000466	0.00358	CcSEcCtD
Cephalexin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000465	0.00357	CcSEcCtD
Cephalexin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000462	0.00354	CcSEcCtD
Cephalexin—Cefonicid—ALB—chronic obstructive pulmonary disease	0.000462	0.141	CrCbGaD
Cephalexin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00352	CcSEcCtD
Cephalexin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000451	0.00346	CcSEcCtD
Cephalexin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000449	0.00345	CcSEcCtD
Cephalexin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.00341	CcSEcCtD
Cephalexin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000443	0.0034	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000442	0.00339	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.00339	CcSEcCtD
Cephalexin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000436	0.00335	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000433	0.00332	CcSEcCtD
Cephalexin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.00328	CcSEcCtD
Cephalexin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000427	0.00328	CcSEcCtD
Cephalexin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00326	CcSEcCtD
Cephalexin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000422	0.00323	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00321	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00321	CcSEcCtD
Cephalexin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00321	CcSEcCtD
Cephalexin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.00321	CcSEcCtD
Cephalexin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000418	0.00321	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.0032	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00315	CcSEcCtD
Cephalexin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00314	CcSEcCtD
Cephalexin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000405	0.00311	CcSEcCtD
Cephalexin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00309	CcSEcCtD
Cephalexin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00308	CcSEcCtD
Cephalexin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00308	CcSEcCtD
Cephalexin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00307	CcSEcCtD
Cephalexin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00307	CcSEcCtD
Cephalexin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000399	0.00306	CcSEcCtD
Cephalexin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.00305	CcSEcCtD
Cephalexin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000397	0.00304	CcSEcCtD
Cephalexin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.00304	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00304	CcSEcCtD
Cephalexin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00303	CcSEcCtD
Cephalexin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000389	0.00298	CcSEcCtD
Cephalexin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000389	0.00298	CcSEcCtD
Cephalexin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00296	CcSEcCtD
Cephalexin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00296	CcSEcCtD
Cephalexin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00294	CcSEcCtD
Cephalexin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00294	CcSEcCtD
Cephalexin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00294	CcSEcCtD
Cephalexin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00294	CcSEcCtD
Cephalexin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000382	0.00293	CcSEcCtD
Cephalexin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00291	CcSEcCtD
Cephalexin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00291	CcSEcCtD
Cephalexin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.00291	CcSEcCtD
Cephalexin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000378	0.0029	CcSEcCtD
Cephalexin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.0029	CcSEcCtD
Cephalexin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.00289	CcSEcCtD
Cephalexin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00288	CcSEcCtD
Cephalexin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00288	CcSEcCtD
Cephalexin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00287	CcSEcCtD
Cephalexin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000372	0.00285	CcSEcCtD
Cephalexin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00284	CcSEcCtD
Cephalexin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00279	CcSEcCtD
Cephalexin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00278	CcSEcCtD
Cephalexin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00278	CcSEcCtD
Cephalexin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00274	CcSEcCtD
Cephalexin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00274	CcSEcCtD
Cephalexin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000357	0.00274	CcSEcCtD
Cephalexin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00269	CcSEcCtD
Cephalexin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00267	CcSEcCtD
Cephalexin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00267	CcSEcCtD
Cephalexin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00263	CcSEcCtD
Cephalexin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00263	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000343	0.00263	CcSEcCtD
Cephalexin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000341	0.00262	CcSEcCtD
Cephalexin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00259	CcSEcCtD
Cephalexin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00258	CcSEcCtD
Cephalexin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00255	CcSEcCtD
Cephalexin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00255	CcSEcCtD
Cephalexin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00252	CcSEcCtD
Cephalexin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000325	0.0025	CcSEcCtD
Cephalexin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00249	CcSEcCtD
Cephalexin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00246	CcSEcCtD
Cephalexin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00246	CcSEcCtD
Cephalexin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00241	CcSEcCtD
Cephalexin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000314	0.00241	CcSEcCtD
Cephalexin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00241	CcSEcCtD
Cephalexin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00237	CcSEcCtD
Cephalexin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00237	CcSEcCtD
Cephalexin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00235	CcSEcCtD
Cephalexin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00235	CcSEcCtD
Cephalexin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00235	CcSEcCtD
Cephalexin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00235	CcSEcCtD
Cephalexin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00233	CcSEcCtD
Cephalexin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00233	CcSEcCtD
Cephalexin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00232	CcSEcCtD
Cephalexin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000302	0.00232	CcSEcCtD
Cephalexin—Rash—Montelukast—chronic obstructive pulmonary disease	0.0003	0.0023	CcSEcCtD
Cephalexin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000299	0.0023	CcSEcCtD
Cephalexin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00228	CcSEcCtD
Cephalexin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.00226	CcSEcCtD
Cephalexin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00224	CcSEcCtD
Cephalexin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00222	CcSEcCtD
Cephalexin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00221	CcSEcCtD
Cephalexin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00221	CcSEcCtD
Cephalexin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00221	CcSEcCtD
Cephalexin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.0022	CcSEcCtD
Cephalexin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00217	CcSEcCtD
Cephalexin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.00214	CcSEcCtD
Cephalexin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00209	CcSEcCtD
Cephalexin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00027	0.00207	CcSEcCtD
Cephalexin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00206	CcSEcCtD
Cephalexin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000267	0.00205	CcSEcCtD
Cephalexin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000264	0.00203	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00202	CcSEcCtD
Cephalexin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00186	CcSEcCtD
Cephalexin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00181	CcSEcCtD
Cephalexin—Ampicillin—ALB—chronic obstructive pulmonary disease	0.000231	0.0708	CrCbGaD
Cephalexin—Cefazolin—ALB—chronic obstructive pulmonary disease	0.000224	0.0684	CrCbGaD
Cephalexin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00166	CcSEcCtD
Cephalexin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00165	CcSEcCtD
Cephalexin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00164	CcSEcCtD
Cephalexin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.0016	CcSEcCtD
Cephalexin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00156	CcSEcCtD
Cephalexin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00153	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00152	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00149	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00147	CcSEcCtD
Cephalexin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00144	CcSEcCtD
Cephalexin—Cefalotin—ALB—chronic obstructive pulmonary disease	0.000186	0.0568	CrCbGaD
Cephalexin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00142	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00133	CcSEcCtD
Cephalexin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00133	CcSEcCtD
Cephalexin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00129	CcSEcCtD
Cephalexin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00127	CcSEcCtD
Cephalexin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00127	CcSEcCtD
Cephalexin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00126	CcSEcCtD
Cephalexin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00126	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00121	CcSEcCtD
Cephalexin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000156	0.0012	CcSEcCtD
Cephalexin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.0012	CcSEcCtD
Cephalexin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00116	CcSEcCtD
Cephalexin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00116	CcSEcCtD
Cephalexin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00116	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00108	CcSEcCtD
Cephalexin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00105	CcSEcCtD
Cephalexin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00104	CcSEcCtD
Cephalexin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000131	0.001	CcSEcCtD
Cephalexin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000969	CcSEcCtD
Cephalexin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000932	CcSEcCtD
Cephalexin—Rash—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000924	CcSEcCtD
Cephalexin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000923	CcSEcCtD
Cephalexin—Headache—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000918	CcSEcCtD
Cephalexin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00087	CcSEcCtD
Cephalexin—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	9.65e-05	0.0643	CbGpPWpGaD
Cephalexin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	8.53e-05	0.0568	CbGpPWpGaD
Cephalexin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	6.97e-05	0.0465	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	3.79e-05	0.0253	CbGpPWpGaD
Cephalexin—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	3.54e-05	0.0236	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	3.38e-05	0.0225	CbGpPWpGaD
Cephalexin—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	2.8e-05	0.0186	CbGpPWpGaD
Cephalexin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	2.71e-05	0.0181	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	2.44e-05	0.0163	CbGpPWpGaD
Cephalexin—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	2.34e-05	0.0156	CbGpPWpGaD
Cephalexin—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	2.25e-05	0.015	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.16e-05	0.0144	CbGpPWpGaD
Cephalexin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	2.1e-05	0.014	CbGpPWpGaD
Cephalexin—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	2.03e-05	0.0135	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.01e-05	0.0134	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	1.99e-05	0.0132	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	1.98e-05	0.0132	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	1.93e-05	0.0129	CbGpPWpGaD
Cephalexin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	1.83e-05	0.0122	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	1.79e-05	0.0119	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	1.79e-05	0.0119	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	1.76e-05	0.0117	CbGpPWpGaD
Cephalexin—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	1.74e-05	0.0116	CbGpPWpGaD
Cephalexin—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.0113	CbGpPWpGaD
Cephalexin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.0111	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	1.64e-05	0.0109	CbGpPWpGaD
Cephalexin—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.0109	CbGpPWpGaD
Cephalexin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.0106	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	1.59e-05	0.0106	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	1.58e-05	0.0105	CbGpPWpGaD
Cephalexin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.0102	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	1.49e-05	0.00994	CbGpPWpGaD
Cephalexin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	1.47e-05	0.00979	CbGpPWpGaD
Cephalexin—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	1.35e-05	0.00897	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	1.33e-05	0.00889	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	1.33e-05	0.00886	CbGpPWpGaD
Cephalexin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.00885	CbGpPWpGaD
Cephalexin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	1.27e-05	0.00849	CbGpPWpGaD
Cephalexin—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.00841	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	1.21e-05	0.00809	CbGpPWpGaD
Cephalexin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.00805	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	1.16e-05	0.00771	CbGpPWpGaD
Cephalexin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.0074	CbGpPWpGaD
Cephalexin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	1.07e-05	0.00712	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	1.06e-05	0.00707	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	1.05e-05	0.00702	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	1e-05	0.00669	CbGpPWpGaD
Cephalexin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	1e-05	0.00666	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.93e-06	0.00662	CbGpPWpGaD
Cephalexin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.71e-06	0.00647	CbGpPWpGaD
Cephalexin—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.58e-06	0.00638	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	9.38e-06	0.00625	CbGpPWpGaD
Cephalexin—SLC47A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	8.79e-06	0.00586	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	8.63e-06	0.00575	CbGpPWpGaD
Cephalexin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.87e-06	0.00524	CbGpPWpGaD
Cephalexin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	7.85e-06	0.00523	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	7.75e-06	0.00517	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.44e-06	0.00496	CbGpPWpGaD
Cephalexin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.05e-06	0.0047	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	7.02e-06	0.00468	CbGpPWpGaD
Cephalexin—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.96e-06	0.00464	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	6.91e-06	0.0046	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	6.63e-06	0.00442	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.49e-06	0.00433	CbGpPWpGaD
Cephalexin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	6.35e-06	0.00423	CbGpPWpGaD
Cephalexin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	6.26e-06	0.00417	CbGpPWpGaD
Cephalexin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.72e-06	0.00381	CbGpPWpGaD
Cephalexin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.7e-06	0.0038	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	5.58e-06	0.00372	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	5.53e-06	0.00369	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	5.39e-06	0.00359	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	5.39e-06	0.00359	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	5.38e-06	0.00359	CbGpPWpGaD
Cephalexin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.15e-06	0.00343	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.03e-06	0.00335	CbGpPWpGaD
Cephalexin—SLC15A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.02e-06	0.00334	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.97e-06	0.00331	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	4.84e-06	0.00322	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	4.67e-06	0.00311	CbGpPWpGaD
Cephalexin—SLC15A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.66e-06	0.0031	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	4.62e-06	0.00308	CbGpPWpGaD
Cephalexin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.61e-06	0.00307	CbGpPWpGaD
Cephalexin—SLC22A5—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.58e-06	0.00305	CbGpPWpGaD
Cephalexin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.55e-06	0.00303	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.47e-06	0.00298	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	4.4e-06	0.00293	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	4.38e-06	0.00292	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	4.28e-06	0.00285	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.28e-06	0.00285	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.25e-06	0.00283	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.18e-06	0.00279	CbGpPWpGaD
Cephalexin—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.14e-06	0.00276	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.12e-06	0.00275	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.94e-06	0.00263	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	3.91e-06	0.0026	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.88e-06	0.00258	CbGpPWpGaD
Cephalexin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.74e-06	0.00249	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.51e-06	0.00234	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.49e-06	0.00232	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	3.48e-06	0.00232	CbGpPWpGaD
Cephalexin—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.46e-06	0.0023	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.44e-06	0.00229	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.29e-06	0.00219	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.25e-06	0.00217	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.2e-06	0.00213	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.18e-06	0.00212	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.18e-06	0.00212	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.16e-06	0.00211	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.15e-06	0.0021	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.04e-06	0.00202	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.03e-06	0.00202	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3e-06	0.002	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	2.96e-06	0.00197	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.93e-06	0.00195	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	2.92e-06	0.00194	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	2.8e-06	0.00187	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	2.78e-06	0.00185	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	2.78e-06	0.00185	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.73e-06	0.00182	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.7e-06	0.0018	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.56e-06	0.00171	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.55e-06	0.0017	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.52e-06	0.00168	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.44e-06	0.00163	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.41e-06	0.0016	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.37e-06	0.00158	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.33e-06	0.00155	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.28e-06	0.00152	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.25e-06	0.0015	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.16e-06	0.00144	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.11e-06	0.00141	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.1e-06	0.0014	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.1e-06	0.0014	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.07e-06	0.00138	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.05e-06	0.00137	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.04e-06	0.00136	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.99e-06	0.00132	CbGpPWpGaD
Cephalexin—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.96e-06	0.00131	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.96e-06	0.00131	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.95e-06	0.0013	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.94e-06	0.0013	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GC—chronic obstructive pulmonary disease	1.91e-06	0.00127	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.77e-06	0.00118	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.76e-06	0.00117	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.62e-06	0.00108	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.6e-06	0.00106	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.57e-06	0.00105	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.52e-06	0.00101	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.46e-06	0.000975	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.41e-06	0.000941	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.41e-06	0.00094	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.39e-06	0.000927	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.37e-06	0.00091	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.29e-06	0.000862	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.26e-06	0.000836	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.06e-06	0.000705	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.06e-06	0.000704	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.04e-06	0.000694	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.03e-06	0.000686	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.03e-06	0.000686	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.01e-06	0.000672	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.57e-07	0.000638	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	9.4e-07	0.000626	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.66e-07	0.000577	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.6e-07	0.000573	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.5e-07	0.000567	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.76e-07	0.000517	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.27e-07	0.000484	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.22e-07	0.000481	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.15e-07	0.000476	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.12e-07	0.000475	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	6.67e-07	0.000445	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.64e-07	0.000442	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.29e-07	0.000419	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.96e-07	0.000397	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.88e-07	0.000392	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.63e-07	0.000375	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.56e-07	0.00037	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	5.49e-07	0.000366	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.48e-07	0.000365	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.2e-07	0.000346	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.07e-07	0.000338	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.67e-07	0.000311	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.09e-07	0.000273	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.9e-07	0.00026	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.85e-07	0.000256	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.58e-07	0.000239	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.53e-07	0.000235	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.4e-07	0.000226	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.38e-07	0.000225	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.31e-07	0.000154	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.21e-07	0.000147	CbGpPWpGaD
